How About A Snootful Of Llama Spray? – IOTW Report

How About A Snootful Of Llama Spray?

It’s good for what ails you.

 

Llama antibodies are extremely small. So tiny that they are able to penetrate all external defenses of the influenza virus and destroy the infectious agent at its core. Intrigued by the possibilities, scientist speculate that a nasal spray of these flu fighters could offer a universal vaccine. More

 

29 Comments on How About A Snootful Of Llama Spray?

  1. I can see it now. Inspired by minute llama anti-bodies, scientist design their own synthetic version meant ward off the common cold. It mutates and kills us all in a generation in some kind of grotesque manner.

    5
  2. I can see it now. Inspired by llama anti-bodies, scientist design a synthetic version of their own. Meant to cure the common cold, it instead mutates and wipes us all out in some grotesque manner.

    8
  3. Now they want to colonize my nose and nasal passages with llama parts?
    Pass, thanx.
    “…the serum would differ from a vaccine in that the antibodies would directly enter humans’ nasal mucus membranes, “so that [the flu virus] never gets a foothold and therefore gives more protection.”
    Do they still teach the ‘chain of infection’ in med schools? This would not do anything for an oral route. Wash your hands, folks! This could lead to a false sense of security, if one were to decline a flu vaccination, believing this nasal implantation would suffice. That could get you to a pandemic quickly. “No thanks, I snorted llama dander- I’m good to go”
    I hear a lot of muslims drink camel piss, that’ll be the next one.
    Wash your hands! With soap and water!

    3
  4. I have a pet llama
    Her name is Enza
    She sneezes tiny antibodies
    When I made a deep inhale
    In flew Enza’s
    Antibodies

    The question that needs asked & answered. Do people in the Andes or people who keep llamas get the flu?

    Just goes to illustrate everything in the world is like a net made with many sizes of mesh.

    3

Comments are closed.